Beware if your CEO is the only insider on an independent board. It can lead to poor financial performance, exorbitant CEO pay, and more financial fraud. This is according to a paper by Associate Professor of Management Christine Shropshire and her co-authors.

Personalized medicine is almost here, says Eric Topol, internationally renowned cardiologist, geneticist, author, and researcher, at the W. P. Carey School of Business' seventh annual McKenna Lecture.